BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35297710)

  • 1. Hesperetin Inhibits TGF-β1-Induced Migration and Invasion of Triple Negative Breast Cancer MDA-MB-231 Cells via Suppressing Fyn/Paxillin/RhoA Pathway.
    Lu Q; Lai Y; Zhang H; Ren K; Liu W; An Y; Yao J; Fan H
    Integr Cancer Ther; 2022; 21():15347354221086900. PubMed ID: 35297710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fyn-Mediated Paxillin Tyrosine 31 Phosphorylation Regulates Migration and Invasion of Breast Cancer Cells.
    Zhang Y; Zheng H; Xu M; Maeda N; Tsunedomi R; Kishi H; Nagano H; Kobayashi S
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paxillin controls actin stress fiber formation and migration of vascular smooth muscle cells by directly binding to the active Fyn.
    Zhang Y; Kishi H; Morita T; Kobayashi S
    FASEB J; 2021 Dec; 35(12):e22012. PubMed ID: 34724245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
    Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
    J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
    Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
    J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
    Zhu X; Wang K; Chen Y
    Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperetin regulates transforming growth factor-β1/Smads pathway to suppress epithelial-mesenchymal transition -mediated invasion and migration in cervical cancer cell.
    Wang J; Chen H; Hu Z; Ma K; Wang H
    Anticancer Drugs; 2021 Oct; 32(9):930-938. PubMed ID: 34016833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of curcumae rhizoma-sparganii rhizoma medicated serum in epithelial-mesenchymal transition in the triple negative breast cancer: Pharmacological role of CR-SR in the TBNC.
    Yin Y; Feng L; Wang L; Ding L
    Biomed Pharmacother; 2018 Mar; 99():340-345. PubMed ID: 29358127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation.
    Yu L; Lin Q; Liao H; Feng J; Dong X; Ye J
    Cell Physiol Biochem; 2010; 26(6):869-78. PubMed ID: 21220918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1.
    Kim HJ; Kim JG; Moon MY; Park SH; Park JB
    J Biol Chem; 2014 Jan; 289(3):1429-40. PubMed ID: 24240172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
    Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
    Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-β1.
    Moon MY; Kim HJ; Kim JG; Lee JY; Kim J; Kim SC; Choi IG; Kim PH; Park JB
    J Cell Physiol; 2013 Nov; 228(11):2119-26. PubMed ID: 23559363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells.
    Mo N; Li ZQ; Li J; Cao YD
    Asian Pac J Cancer Prev; 2012; 13(11):5709-14. PubMed ID: 23317243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
    Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
    BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic acid attenuates TGF-β1-stimulated collagen gel contraction via suppression of RhoA/Rho-kinase pathway in hypertrophic scar fibroblasts.
    Hsieh SC; Wu CC; Hsu SL; Feng CH; Yen JH
    Life Sci; 2016 Sep; 161():19-26. PubMed ID: 27457401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
    Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
    Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.